目录产品 » AmMag™ Quatro 1300
Manual
COAs

AmMag™ Quatro 1300

该产品已下架。
AmMagᵀᴹ Quatro 1300 is an advanced automated solution designed for the efficient purification of high-quality antibodies and proteins from both eukaryotic and prokaryotic expression systems.
D00045
咨询产品问题
Description

简介
AmMag™ Quatro 1300 全自动蛋白 / 抗体磁珠纯化系统，一次最多可运行多达 12 个样品，由混匀磁吸模块、加液模块及耗材转盘等组成，可实现全自动纯化流程。
搭配 GenScript 蛋白/抗体纯化磁珠，可满足各类蛋白纯化需求。

概述
AmMag™ Quatro 1300 是基于磁珠法的蛋白 / 抗体纯化方法。可以全自动完成磁珠孵育、洗杂、洗脱以及磁珠再生等流程。仪器同时具备 6 个独立加液管路，可以由用户自由配置使用。

D00045C


规格

自动化 一步实现从样本加载到终产物收集
通量 12 个样本/运行
试剂通道 6 通道
纯化方法 基于磁珠法的蛋白 / 抗体纯化方法
适配容器 25 mL 离心管、50 mL 离心管及 100 mL 离心管
尺寸
长×宽×高
(L x W x H)		 630 mm×703 mm×668 mm
电源 电压： 100-240 VAC
频率： 50/60 Hz
额定功率：500 W
安装环境 环境温度： 18 ℃ ~ 32 ℃
相对湿度： ≤ 85%，无凝露
高度： ≤ 2000 m
注意：避免接触外部电磁干扰

相关文献
Lauren Gebhardt, et al. A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology. Antibodies. (2025-10)
Jeremy Shek; Chen Sun; Elise M. Wilson; Fatemeh Moadab; Kathryn M. Hastie; Roshan R. Rajamanickam; Patrick J. Penalosa; Stephanie S. Harkins; Diptiben Parekh; Chitra Hariharan; Dawid S. Zyla; Cassandra Yu; Kelly C. L. Shaffer; Victoria I. Lewis; Ruben Diaz Avalos; Tomas Mustelin; Erica Ollmann Saphire, et al. Human endogenous retrovirus K (HERV-K) envelope structures in pre- and postfusion by cryo-EM. SCIENCE ADVANCES. (2025-08)
Aishwarya Venkatramani, et al. Modifying recombinant purple acid phosphatase using computational design. European Biophysics Journal. (2025-07)
Emre Fertan; Jeff Y. L. Lam; Giulia Albertini; Maarten Dewilde; Yunzhao Wu; Oluwatomi E. S. Akingbade; Dorothea B ken; Elizabeth A. English; Bart De Strooper; David Klenerman, et al. Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's disease. Alzheimer's & Dementia. (2025-04)
Fernanda Ana-Sosa-Batiz; Shailendra Kumar Verma; Norazizah Shafee; Robyn Miller; Chris Conner; Kathryn M. Hastie; Julia Timis; Erin Maule; Michael N. Nguyen; Linda Tran; Krithik Varghese; Henry Madany; Audrey Elizabeth Street; Michelle Zandonatti; Meng Ling Moi; Kurt Jarnagin; David R. Webb; Erica Ollmann Saphire; Kenneth Kim; Sujan Shresta, et al. A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. EBioMedicine. (2025-03)
Marie-Lynn Cuypers; Tom Jaspers; Jarne Clerckx; Simon Leekens; Christopher Cawthorne; Guy Bormans; Frederik Cleeren; Nick Geukens; Bart De Strooper; Maarten Dewilde, et al. Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein. Fluids and barriers of the CNS. (2025-01)
Montader Ali, et al. Automated optimization of the solubility of a hyper-stable α-amylase. Open Biol. (2024-05)
Karina L. Bursch; Christopher J. Goetz; Guanming Jiao; Raymundo Nu ez; Michael D. Olp; Alisha Dhiman; Mallika Khurana; Michael T. Zimmermann; Raul A. Urrutia; Emily C. Dykhuizen; Brian C. Smith, et al. Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression. The Journal of Biological Chemistry. (2024-04)
Rajeshwer S Sankhala , et al. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques. Nat Commun. (2024-01)
Kathryn M Hastie, et al. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep. (2023-04)
I-Ting Teng, et al. Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron. PLoS ONE. (2021-12)
Vincent Dussupt, et al. Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations. Nat Immunol. (2021-10)
查看更多
返回